Insider Selling: Centene Corporation (CNC) EVP Sells 5,000 Shares of Stock
Centene Corporation (NYSE:CNC) EVP Keith H. Williamson sold 5,000 shares of the stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $100.11, for a total transaction of $500,550.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Centene Corporation (CNC) traded up $1.84 during mid-day trading on Wednesday, reaching $104.43. 1,150,000 shares of the company’s stock traded hands, compared to its average volume of 1,440,000. The company has a current ratio of 0.99, a quick ratio of 0.99 and a debt-to-equity ratio of 0.71. Centene Corporation has a 52-week low of $56.00 and a 52-week high of $104.65. The company has a market cap of $18,020.00, a price-to-earnings ratio of 21.58, a P/E/G ratio of 1.26 and a beta of 0.70.
Centene (NYSE:CNC) last released its earnings results on Tuesday, October 24th. The company reported $1.35 EPS for the quarter, beating the consensus estimate of $1.24 by $0.11. Centene had a net margin of 1.81% and a return on equity of 14.79%. The firm had revenue of $11.90 billion for the quarter, compared to analyst estimates of $11.75 billion. During the same period last year, the firm earned $1.12 EPS. The business’s quarterly revenue was up 9.7% compared to the same quarter last year. equities research analysts forecast that Centene Corporation will post 4.99 EPS for the current fiscal year.
CNC has been the subject of a number of research reports. Jefferies Group raised their target price on shares of Centene from $98.00 to $112.00 and gave the stock a “buy” rating in a research note on Friday, October 13th. Oppenheimer restated a “buy” rating and set a $105.00 target price on shares of Centene in a research note on Friday, September 29th. Cantor Fitzgerald restated a “buy” rating and set a $107.00 target price on shares of Centene in a research note on Tuesday, October 24th. Cowen restated a “buy” rating and set a $115.00 target price on shares of Centene in a research note on Tuesday, October 24th. Finally, Zacks Investment Research upgraded shares of Centene from a “hold” rating to a “buy” rating and set a $107.00 target price for the company in a research note on Friday, September 15th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $104.21.
Centene Company Profile
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.